NIH-funded research R01 grant

Understanding how certain proteins help cells change their function

Official title: Role of nucleosome architecture in cellular reprogramming

Funded at University of North Dakota · NIH-11100881 · Data updated 2026-11-12

This study is looking at how certain proteins help change the way cells work by opening up their DNA, which could help us understand how problems with these proteins might be connected to diseases like cancer.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of North Dakota
NIH-funded
Lab location1 site (Grand Forks, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$210,000
NIH project number3R01GM148729-02S1
Project IDNIH-11100881 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with cancers or conditions linked to cellular reprogramming and chromatin misregulation.

Less likely to help

Patients with conditions unrelated to cellular reprogramming or chromatin structure may not benefit from this research.

What this research studies

This research investigates how specific proteins, known as pioneer factors, interact with chromatin to facilitate cellular reprogramming. By examining the mechanisms through which these proteins can open up tightly packed DNA structures, the study aims to uncover how cells can switch their functions effectively. The research employs advanced techniques like cryo-electron microscopy to visualize these interactions at a molecular level. This understanding could lead to insights into how misregulation of these factors is linked to diseases such as cancer.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating diseases related to cellular reprogramming, including various cancers.

How similar studies have gone: Other research has shown promising results in understanding the role of pioneer factors in cellular processes, indicating that this approach has potential for significant breakthroughs.

Where this research is happening

  • University of North Dakota
    Grand Forks, United States
    Active

Researchers

  • Principal investigator: Takaku, Motoki — University of North Dakota
  • Study coordinator: Takaku, Motoki

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.